Related Experiment Video
Updated: Oct 12, 2025

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
Published on: November 3, 2016
Approach to Neurological Channelopathies and Neurometabolic Disorders in Newborns
Inn-Chi Lee1,2
1Division of Pediatric Neurology, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Insights
Newborns with channelopathies can experience seizures mimicking neurometabolic disorders. Early diagnosis is crucial for neurodevelopmental outcomes in these critical infant channelopathies.
Area of Science:
- Neonatal neurology
- Genetics
- Pediatric epilepsy
Background:
- Ion channel disorders (channelopathies) affect newborns, impacting the central nervous system and skeletal muscle.
- Neonatal seizures are a key manifestation, often presenting similarly to neurometabolic disorders.
- Seizure severity varies, from mild to severe epileptic encephalopathies with potential developmental regression and mortality.
Purpose of the Study:
- To highlight the diagnostic challenges of channelopathies in newborns.
- To emphasize the importance of distinguishing channelopathies from neurometabolic disorders.
- To underscore the need for early and accurate diagnosis for improved neurodevelopmental outcomes.
Main Methods:
- Review of clinical presentations of channelopathies in neonates.
- Comparison of seizure characteristics between channelopathies and neurometabolic disorders.
- Discussion of diagnostic strategies for differentiating these conditions.
Main Results:
- Channelopathies present with focal or generalized seizures in newborns.
- Clinical presentation can closely mimic neurometabolic disorders, complicating diagnosis.
- Delayed diagnosis can lead to adverse neurodevelopmental consequences.
Conclusions:
- Early identification of channelopathies in newborns is critical.
- A systematic diagnostic approach is essential to differentiate from neurometabolic disorders.
- Timely diagnosis and management improve long-term neurodevelopmental prognosis for affected infants.
Abstract:
Ion channel disorders (channelopathies) can affect any organ system in newborns before 2 months of life, including the skeletal muscle and central nervous system. Channelopathies in newborns can manifest as seizure disorders, which is a critical issue as early onset seizures can mimic the presentation of neurometabolic disorders. Seizures in channelopathies can either be focal or generalized, and range in severity from benign to epileptic encephalopathies that may lead to developmental regression and eventually premature death. The presenting symptoms of channelopathies are challenging for clinicians to decipher, such that an extensive diagnostic survey through a precise step-by-step process is vital. Early diagnosis of a newborn's disease, either as a channelopathy or neurometabolic disorder, is important for the long-term neurodevelopment of the child.
Related Concept Videos
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

